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ABSTRACT
Introduction There is growing recognition among 
health researchers and funders that the wider benefits 
of research such as economic, social and health impacts 
ought to be assessed and valued alongside academic 
outputs such as peer-reviewed papers. Research 
translation needs to increase and the pathways to impact 
ought to be more transparent. These processes are 
particularly pertinent to the Indigenous health sector given 
continued concerns that Indigenous communities are 
over-researched with little corresponding improvement 
in health outcomes. This paper describes the research 
protocol of a mixed methods study to apply FAIT 
(Framework to Assess the Impact from Translational 
health research) to the Centre for Research Excellence 
in Integrated Quality Improvement (CRE-IQI). FAIT will 
be applied to five selected CRE-IQI Flagship projects to 
encourage research translation and assess the wider 
impact of that research.
Methods and analysis Phase I will develop a modified 
programme logic model for each Flagship project including 
identifying process, output and impact metrics so progress 
can be monitored. A scoping review will inform potential 
benefits. In phase II, programme logic models will be 
updated to account for changes in the research pathways 
over time. Audit and feedback will be used to encourage 
research translation and collect evidence of achievement 
of any process, output and interim impacts. In phase 
III, three proven methodologies for measuring research 
impact—Payback, economic assessment and narratives—
will be applied. Data on the application of FAIT will be 
collected and analysed to inform and improve FAIT’s 
performance.
Ethics and dissemination This study is funded by 
a nationally competitive grant (ID 1078927) from the 
Australian National Health and Medical Research Council. 
Ethics approval was obtained from the University of 
Newcastle’s Human Research Ethics Committee (ID: 
H-2017–0026). The results from the study will be 
presented in several peer-reviewed publications, through 
conference presentations and via social media.
InTRoduCTIon
A substantial amount of health and medical 
research does not translate, is not imple-
mented by healthcare systems, is not used by 
end users in policy and practice, and does 
not create impact.1 Research translation is 
the process of knowledge generation and 
transfer that enables those utilising the devel-
oped knowledge to apply it.2 The definition 
for ‘research impact’ modified for the health 
and medical research context and used in 
this protocol is the demonstrable effect from basic, 
health systems, patient and population-orientated 
research, and clinical trials that ultimately improves 
healthcare delivery, human health and quality of 
life, and generates benefits for the economy, society, 
culture, public policy or the environment.3 Any 
level of suboptimal translation means the 
returns earned from research investments do 
not achieve their potential. Further, in terms 
of the broader fiscal environment, there 
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Protocol
Strengths and limitations of this study
 ► The proposed study uses a comprehensive mixed 
method four-phase design to validate a framework 
to encourage research translation and measure 
research impact.
 ► The study incorporates a process evaluation to 
understand users’ experience of the framework.
 ► Measurement of impact uses three proven methods 
for impact assessment—Payback (modified), 
economic evaluation and narratives.
 ► The time lag between translation and impact means 
impacts may not have been realised at the point 
of assessment. Impact assessment in this study 
is limited to five research projects rather than the 
Centre for Research Excellence in Integrated Quality 
Improvement as a whole programme.
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is a growing demand for more accountability in public 
spending across all sectors, including health.4
A contributor to suboptimal translation and impact 
is that research translation has not been systematically 
encouraged, and impact measurement beyond academic 
outputs such as peer-reviewed publications while 
becoming more common in countries like the UK5 is still 
not standard practice in most other countries.6 There 
are a plethora of impact measurement frameworks avail-
able and several studies including two recent systematic 
reviews of these frameworks, models and applications.7–9 
However, there is a lack of evidence to suggest that the 
availability of these frameworks and models has actually 
increased the proportion of health and medical research 
projects that actually measure and report on impact, 
rather than just outputs. There is growing recognition 
that translation of research into policy and practice needs 
to increase and that the pathways to realising impact 
ought to be more transparent.10 There have been several 
studies trialling the use of impact measurement appli-
cations in Australia,11–15 but a national framework for 
measurement of research impact has not yet been imple-
mented. However, there have been major developments 
in this space. Key initiatives include the following:
 ► The Excellence in Research for Australia (ERA), a 
national framework to examine how universities are 
translating their research into economic, social and 
other benefits13
 ► Australia’s National Health and Medical Research 
Council’s (NHMRC's) Advanced Health Research 
and Translation Centres programme16
 ► Medical Research Futures Fund to support transla-
tional medical research17
 ► Australian Research Council’s (ARC's) development 
and piloting of a national engagement and impact 
assessment framework to sit alongside the current 
ERA12
 ► NHMRC’s Centres for Innovation in Regional Health18
 ► Australia’s National Innovation and Science Agenda, 
which has dedicated $9 million to assess and report on 
the engagement and impact of university research.19
These initiatives confirm that research translation 
and impact assessment are high on Australia’s research 
agenda, and attempts to close the gap between research 
outputs and impacts will be highly regarded.
In Australia, this need for greater accountability is partic-
ularly evident in the area of Aboriginal and Torres Strait 
Islander (thereafter respectfully referred to as Indigenous 
Australians) health, where health disparities continue 
between Indigenous and non-Indigenous Australians.20 21 
There remain serious concerns that Indigenous Austra-
lians have been over-researched without corresponding 
improvements in health outcomes.22 One reason for this 
has been the overabundance of descriptive studies in 
Indigenous health that, of themselves, rarely translate 
to changes in policy and practice. A recent systematic 
review of reviews of Indigenous health and well-being 
research identified knowledge and methodological gaps 
in documenting Indigenous health research impact and 
found that not one of the reviews assessed the impact 
of research nor explicitly referred to research impact.23 
More needs to be done to ensure that Indigenous health 
research improves the quality of health and health-related 
services delivered to Indigenous communities, and ulti-
mately improves the health and well-being of the Indige-
nous community. Consideration of ‘value for money’ must 
be a component of determining the success or failure of 
health and well-being programmes. Currently, govern-
ment agency reporting is based largely on inputs and 
outputs rather than impacts, and the absence of robust 
and available outcome data has been a significant barrier 
to assessing impacts. In a debate-style article on the bene-
fits of Indigenous health research, the authors concluded 
that adopting a benefit-led approach and embedding the 
assessment of benefit from the outset of the research is a 
vital prerequisite to maximising research impact.22
Recognising a need to enhance continuous quality 
improvement (CQI) initiatives in Indigenous primary 
healthcare (PHC), the NHMRC funded the Centre for 
Research Excellence in Integrated Quality Improve-
ment in Indigenous PHC (CRE-IQI) from 2015 to 
2019. The vision for CRE-IQI is to improve Aborig-
inal and Torres Strait Islander health outcomes by 
accelerating and strengthening large-scale PHC 
quality improvement efforts. Building on the part-
nership learning model24 developed through earlier 
research, and on innovation platform concepts, the 
CRE-IQI brings together stakeholders from across 
different levels of the health system (clinical, policy, 
service coordination and support) to share and 
exchange their experiences, knowledge, skills, ideas 
and resources to accelerate and strengthen systems-
level PHC improvement efforts. A significant portion 
of CRE-IQI resources are dedicated to the func-
tioning and improvement of the innovation platform 
and cross-cutting programmes including research 
capacity-strengthening, strengthening collaboration 
and research translation. Specifically, a portion of its 
funding has been allocated to adopting a framework 
to encourage research translation and assess impact 
of its research programme. The selected Frame-
work to Assess the Impact from Translational health 
research (FAIT) was developed by a team of health 
economists and health and medical researchers based 
at the Hunter Medical Research Institute with the 
specific aim of encouraging and measuring research 
translation and impact. The framework was based 
on a mixed methods study involving (1) a scoping 
review of existing research impact frameworks and 
techniques to inform the development of FAIT; (2) a 
development stage to design the prototype; and (3) a 
feedback stage where iterations of the prototype were 
presented to selected researchers for discussion and 
refinement.25 The adoption of FAIT by CRE-IQI pres-
ents an opportunity to pilot the framework’s imple-
mentation and trial its research impact assessment 
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Table 1 CRE-IQI Flagship projects selected for implementation of FAIT 
Project title Project synopsis
Years in 
progress
Type of FAIT 
implementation
Engaging stakeholders 
in identifying priority 
evidence–practice 
gaps and strategies for 
improvement in primary 
healthcare (ESP Project)
The ESP Project brings together the concept of knowledge 
cocreation and evidence on how to achieve large-scale 
change in quality of care. It engages a wide range of 
stakeholders in using aggregated continuous quality 
improvement data to identify priority gaps in care, barriers 
and enablers and strategies for improvement.33
2014–current Retrospective and 
prospective
Ongoing collaborative 
analysis and reporting of 
data from the Audit and 
Best Practice in Chronic 
Disease National 
Research Partnership 
(ABCD Partnership)
The ABCD Partnership investigates the variation in quality 
of care in Indigenous primary healthcare centres. It also 
explores the underlying factors associated with variation at 
the health centre and regional level, and examines specific 
strategies that have been effective in improving primary care 
clinical performance. This information will be used to work 
with health service staff, management and policy makers 
to enhance the effective implementation of successful 
strategies.34
2010-current Retrospective and 
prospective
Quality improvement 
in Aboriginal primary 
healthcare: lessons from 
the best to better the 
rest
This project examines six ‘high improving’ PHC services 
within the ABCD cohort to enhance understanding of 
how contextual factors interact to facilitate the success of 
continuous quality improvement (CQI) initiatives within a 
service. The findings will be used to assist striving services to 
increase their success in implementing CQI initiatives.35
2014–2017 Retrospective and 
prospective
Strategies for improving 
provision of maternal 
care for Aboriginal and 
Torres Strait Islander 
women
This project aims to use the ABCD data to ascertain which 
combination of components of pregnancy care has the 
largest positive impact on birth outcomes. This information 
will be used to develop a list of essential pregnancy care 
items, a tool and accompanying resources for health services 
to implement these essential care items. The project will 
also work with stakeholders to further develop strategies to 
improve maternal health outcomes.36
2017–2019 Prospective
Sustainable Family 
Well-Being (FWB) 
implementation and 
evaluation using CQI 
approaches
This project will define and develop implementation 
mechanisms that support FWB empowerment programme 
integration and implementation within family support 
programmes. This includes the development of evidence-
informed funding models, mechanisms and sustainable ways 
of embedding FWB and upscaling proven family support 
programmes and services.36
2015–2019 Retrospective and 
prospective
CRE-IQI, Centre for Research Excellence in Integrated Quality Improvement; FAIT, Framework to Assess the Impact from Translational health 
research; PHC, primary healthcare
methodology. The framework will be applied to five 
selected Flagship projects to present transparency to 
the translation process, provide capacity to improve 
the speed of translation (when applied prospectively), 
and ultimately to assess the impact of these research 
projects (see table 1 for details of each project).
The remainder of this paper focuses on the research 
protocol of a mixed methods study to document the 
pathway to translation (including engagement with stake-
holders and barriers and enablers of translation) and 
measure the impact of the five aforementioned proj-
ects—all of which are at different stages of the research 
pipeline. There are four objectives for this study:
1. provide transparency about the pathway to generating 
research impact
2. examine process issues associated with the implemen-
tation of FAIT
3. test the feasibility of using FAIT’s package of validated 
impact assessment methodologies
4. assess the impact of the five Flagship projects.
The anticipated outcome of this study will be greater 
translation of research among CRE-IQI associates and 
others working in this field. It is also anticipated that the 
study will provide an evidence-based report of the impact 
of the five CRE-IQI projects and evidence to other health 
services researchers wishing to implement a framework to 
encourage greater translation and optimise and measure 
their research impact.
METhodS And AnAlySIS
This study involves the application of a specific framework 
(FAIT) to encourage research translation and measure 
research impact.25 The setting will be the CRE-IQI. 
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Figure 1 CRE-IQI timeline for implementation of FAIT. CRE-IQI, Centre for Research Excellence in Integrated Quality 
Improvement in Indigenous Primary Healthcare; FAIT, Framework to Assess the Impact of Translational health research.
While the CRE has a project coordinating centre in 
Lismore, New South Wales, its work is largely carried 
out through collaborative teams from multiple organi-
sations including community-controlled health services, 
government health services, policy organisations, univer-
sities and research institutions across New South Wales, 
Queensland, the Northern Territory, South Australia and 
Western Australia. Participants in data collection will be a 
mix of researchers and students who are associated with 
CRE-IQI and collaborators in related fields such as health 
service staff, clinicians, policy makers, representatives of 
peak Indigenous health organisations and Indigenous 
community members.
The study design will involve a four-stage sequential 
mixed method design, summarised below:
 Phase I: A modified programme logic model of 
CRE-IQI’s five selected Flagship research programmes 
will be developed with input from key stakeholders. The 
models will be developed retrospectively for ongoing 
research projects and prospectively for newly instigated 
initiatives. Part of this process will include a scoping 
review to identify categories of impact that will inform 
the type of benefits that may be expected to result from 
research into integrated quality improvement in Indige-
nous PHC and to identify potential values or sources of 
value associated with those benefits.
Phase II: The implementation of FAIT focusing on data 
collection (process, outcome and impact metrics). This 
stage will also incorporate a process evaluation to collect 
participants’ perceptions of FAIT and its implementation.
Phase III: The impact of the five Flagship projects will 
be measured and evaluated using the package of FAIT 
methodologies for impact assessment, namely ayback,26 
economic assessment and case studies. The results will 
be summarised and presented by way of a scorecard, 
including narratives describing the process by which 
the research translated and generated impact.
Phase IV: The outcomes of both the implementation 
of FAIT and the results of the assessment of the five Flag-
ship projects will be compiled. This report will include 
recommendations for the future implementation of FAIT 
in Indigenous health research settings.
The approximate timelines for the various activities 
and key dates are summarised in figure 1.
The following sections provide details about the 
methods for each of these four phases of the study.
Phase I
A modified programme logic model
The first phase will be the creation of five modified 
programme logic models.25 One of the modifications to 
the logic model as used in FAIT relates to the insertion 
of ‘end users’, which has the advantage for impact assess-
ment purposes of identifying who will use the research 
outputs. However, in the context of CRE-IQI, end users 
are defined as collaborators along the pathway to impact 
that are both cocreators and co-users of the research 
outputs, including CQI coordinators, other health service 
staff, clinicians, policy makers, representatives of peak 
Indigenous health organisations and Indigenous commu-
nity members. This definition includes both interim 
and final users. A further modification is the introduc-
tion of process and output metrics in addition to impact 
metrics to provide greater transparency between the 
aims and intended impacts of the research. The purpose 
of the logic models will be to provide a strategic map of 
how each of the five Flagship projects plans to generate 
impact. The logic models link community and other 
needs to the research priorities and activities. These activ-
ities should produce an output that when used by an end 
user creates an opportunity for the generation of impact. 
While recognising that translation is a multidirectional 
phenomenon, this approach provides ‘line of sight’ from 
need to research to impact (see figure 2).
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Figure 2 Modified programme logic model.
The value in articulating these processes in a 
programme logic model gives transparency to how the 
research producers believe their project will generate 
impact. The programme logic model provides insights 
about the planned activities, expected outputs and 
intended impacts. This information is used to determine 
a series of metrics to measure the project’s progress 
against plans. Process metrics not only allow researchers 
to determine if the research is going to plan, they are an 
opportunity to include activities that have, in the liter-
ature, been associated with successful translation and 
the generation of impact. Output metrics help identify 
when key outputs or products of the research activity 
have been generated. Impact metrics are measures that 
reflect the consequence of the research output being 
used by end users. For example, a new clinical guide-
line might be the product of a Flagship project, but 
it will need to be used or implemented by clinicians 
before it can generate impact such as improved patient 
outcomes.
Data for the given programme logic models will be 
obtained through a series of semistructured individual 
and group telephone interviews with key stakeholders 
from each project and group feedback sessions to ensure 
all perspectives are covered. For projects that are further 
along the research pipeline, information obtained from 
researchers and collaborators will be triangulated against 
existing documents such as published papers, and other 
project documents including meeting minutes and prog-
ress reports.
With the prospective application of FAIT, the modi-
fied programme logic model will be used to discern the 
relevant research outputs and to describe the expected 
impacts when used by the end users. In a retrospec-
tive application, it will be used to give clarity to the 
extent to which research translation and impact were 
given consideration at the programme outset. While 
the programme logic model appears linear within this 
diagrammatic representation (necessary for the devel-
opment of a logic model), its application, including 
project development, stakeholder engagement and 
project refinement, is in most part non-linear and itera-
tive in nature. Hence the programme logic models will 
be living documents open to change at all stages of the 
research to ensure they capture the actual translational 
pathways to impact.
Scoping review
The development of the programme logic models will be 
informed by a scoping review. The objective of the review 
will be to identify categories of impact that will inform 
the benefits that may be expected from research about 
integrated quality improvement in Indigenous PHC. It 
will also be used to identify potential values or sources of 
value associated with those anticipated benefits.
The review process will follow the Joanna Briggs Insti-
tute (JBI) guideline for scoping reviews.27 While still 
methodical, scoping reviews are typically broader in 
their focus with less restrictive inclusion criteria than 
systematic reviews.28 The review will be used to map the 
key concepts underpinning the measurement of impact 
on the delivery of health services to Indigenous popula-
tions. As outlined in the JBI guideline, a three-step search 
strategy will be used and a provisional search strategy is 
described here. Step 1 of the review will be conducted 
using combinations of the following free text and medical 
subject heading (MeSH) terms in the titles and abstracts 
of articles from two online databases: Indigenous health 
research, health services research, CQI, integrated quality 
improvement, research impacts, knowledge generation, 
health impacts, health outcomes and economic impacts. 
Step 2 will be an analysis of the text words contained in 
the title and abstract of any retrieved papers and of the 
index terms used to describe the articles. A second search 
will then be undertaken using all identified keywords 
and index terms across all included databases. Third, 
the reference list of all identified reports and articles will 
be hand-searched for additional studies. In this review, 
literature will be drawn from both economic (ie, EconLit 
and JSTOR) and general health and medical academic 
databases (ie, Medline, Embase, The Cumulative Index 
to Nursing and Allied Health Literature, Cochrane Data-
base of Systematic Reviews). The searches will also extend 
to Google Scholar and Google to identify grey literature 
from government departments, international organ-
isations and research funders, including information 
of potential grey and published literature identified by 
CRE-IQI members and affiliates during the programme 
logic development phase. The searches will be limited 
to articles published in English between 1995 and 2017. 
This time frame is considered to be appropriate because 
knowledge translation, a precursor to impact assessment, 
first gained prominence in the late 1990s.
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The data from the review will be charted to record 
the key information. In line with recommended scoping 
review guidelines, the charting of results will be itera-
tive.27 28 The tabulated results will be accompanied by a 
narrative aligned to the review objective. The findings will 
be used to inform the domains of benefit and valuations 
for inclusion in the Payback and economic assessment of 
Flagship projects. No formal assessment of the quality of 
the studies will be undertaken and the results will not be 
published.
Phase II
Implementation of the FAIT framework
Phase II of the study will be the implementation of 
the FAIT framework over the remaining 24 months 
of CRE-IQI operations until the end of July 2019. This 
will entail sharing the programme logic models with all 
CRE-IQI associates, allowing for feedback and modifica-
tions to the five models and 6-monthly updating of the 
models including any modifications to expectations and 
predefined activities. Through a process of audit and 
feedback, Flagship project teams will have the opportu-
nity to assess how they are tracking against their output 
and impact goals and to refine their research transla-
tion and engagement activities to maximise impact. In 
addition, CRE-IQI associates will be exposed to current 
thinking around research translation, implementation 
and impact through CRE-IQI’s research capacity strength-
ening programme.
Data collection for this stage of the study will involve 
a series of online and telephone surveys of CRE-IQI 
management and associates to elicit their perceptions 
of FAIT, determine if the framework encourages trans-
lational behaviours and how the implementation of the 
framework can be improved. Participants will also be 
asked to articulate which aspects of the framework work 
well and which aspects need refinement.
Phase III
Research impact measurement and valuation
Currently, there is no single measurement method capable 
of capturing the impacts stemming from health and 
medical research. For this reason, FAIT employs a combi-
nation of three integrated but separate proven impact 
assessment methods: quantified metrics,29 economic 
assessment30 and narratives of the process by which the 
research in question translates and generates impact. 
Using qualitative project examples, the case studies will 
be triangulated against the Payback and economic assess-
ment to validate the impact of the research in question.
Metrics—modified Payback
The metrics referred to in FAIT are a variation of the 
methods used in the Payback Framework.26 Metrics will be 
organised under broad domains of benefit such as knowl-
edge impacts, impacts on practice, economic impacts, 
policy impacts and community impacts. Semi-structured 
interviews and group discussions with each Flagship 
project team will be used to generate process, output 
and impact metrics that will be used to populate the 
domains of benefit within Payback. These metrics will be 
structured to support the planned economic assessment. 
Robust metrics that are contextually relevant to Indige-
nous health research will be selected with consideration 
to objectivity, administrative efficiency, transparency and 
comparability, as well as their ability to be verified.
In cases that involve the retrospective application of 
FAIT, examples of process metrics will include the histor-
ical level of engagement with key stakeholders as well 
as activities that could assist the translation of research 
outputs through to others in the research pipeline. With 
retrospective analysis, the metrics may necessarily be 
constrained to outcome measures selected at the research 
programme outset to measure the efficacy of the research 
components—for example, changes in organisational 
systems that support the adoption of CQI within those 
health services that are involved in translation of findings 
from Lessons from the Best.
Economic assessment
The economic assessment component will entail a 
comparison of the costs associated with developing and 
implementing the five Flagship projects versus (where 
feasible) a calculated value for the expected impact or 
consequence of the funded research. The descriptive 
nature of much of CRE-IQI work will impact on the 
type of economic assessment that is feasible and useful. 
The planned assessment will collect, on a case-by-case 
basis, the resources used to fund the research, including 
non-CRE funding expended on each project prior to the 
commencement of CRE-IQI. The cost of running the 
CRE-IQI programme will be appropriately apportioned 
across the five Flagship projects (these projects repre-
sent the major investment of the CRE), keeping in mind 
that programmes such as the capacity strengthening 
programme benefit a range of other CRE-IQI-affiliated 
projects and partners. Additional costs in utilising the 
research outputs of each project will also be included. 
For example, research that develops a minimum package 
of pregnancy care content for implementation will have 
used resources to develop and evaluate the package. 
Implementation of that package might increase the 
number of maternal prenatal care consults or diagnostic 
tests. These consults and tests are additional costs to the 
health system and can be modelled on the Cooperative 
Research Council-endorsed evaluation framework—
the Impact Tool—which uses cost benefit analysis as its 
foundation. Implementation of that minimum package 
might also have positive impacts on preterm birth, low 
birth weight and small-for-gestational age, which can be 
reported as downstream savings to the health system. The 
appeal in using the tool to guide the economic assess-
ment stems from the emphasis on the logic underpin-
ning the research activity–output–usage–impact chain 
to give transparency and clarity to the research, which is 
also at the heart of FAIT. The programme logic model 
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will assist in articulating programme inputs, expected 
outputs, uptake and ultimate impact. The total calculated 
expected costs and benefits will be combined by way of an 
impact map. Depending on the focus and stage of each 
Flagship project, three broad steps will be involved in the 
economic assessment: (1) identification and measure-
ment of resource use; (2) measurement and valuation of 
the expected impact, where possible; and (3) comparison 
of the costs and expected impacts, where possible, in a 
single metric. Where practical, the analysis will assume a 
societal perspective to ensure all possible costs and bene-
fits are accounted for. Expected costs and impacts will 
be reported in net present value terms and streams of 
projected future costs and benefits will be discounted at 
a rate of 3%.
Identification, measurement and valuation of resource use
Guided by the programme logic model, resource use 
pertaining to (1) the development of the research, (2) 
delivery of any research outputs or interventions, (3) 
uptake of outputs by end users and (4) health service 
changes will be identified, measured and valued. The 
retrospective nature of the application of FAIT to a 
majority of the Flagship projects will hamper the collec-
tion of data to inform many of the costs and benefits. This 
is especially true for costs incurred as a result of adopting 
or using the research outputs of each CRE-IQI project.
Resource use associated with development and delivery 
of the various projects will be costed using financial 
and administrative records from the respective research 
teams. Where appropriate, the costs associated with trans-
lation of the project findings and outputs will include 
any costs (including opportunity costs) incurred by the 
various health service organisations, such as costs related 
to practice change. As stated above, it will be problem-
atic to collect data to inform these costs retrospectively. 
However, some attempt will be made to model these costs 
using administration records and detailed descriptions 
of uptake obtained from programme managers and CQI 
facilitators to inform the modelling.
Unit costs for health service resource use, where 
appropriate and available, will be based on the best avail-
able data at the time, including the Medicare Benefits 
Schedule.31 Resource use of marketed goods and services 
outside the health sector will be valued at current market 
prices. Unmarketed goods and services such as travel time 
and the time of volunteers will be costed using opportu-
nity cost prices.
Measurement and valuation of the expected impact
Impact will be calculated for selected domains from 
each of the five programme logic models. The calcula-
tions will be adjusted for risk to give the expected value 
of the impact. Attribution will be assigned at a conserva-
tive rate, the value of which will be informed by adminis-
trative and evaluation records and qualified during the 
researcher and health service staff interviews. Projected 
valuations will include a ‘drop-off’ factor to account for 
waning benefit over time. The sensitivity of the impact 
calculation to changes in attribution and drop-off will be 
extensively tested. Any and all assumptions underpinning 
the analysis will be made explicit in the reporting of the 
results. The economic assessment will be limited to assess-
ments for which there is existing evidence or for which 
evidence can be collected.
Narratives (case studies)
The FAIT approach also incorporates the use of illus-
trative examples or narratives which will be compiled 
for each Flagship project to describe in more qualitative 
terms how translation occurred and how research impact 
was generated for each project.25 Narratives can be 
powerful tools for communicating the nature and extent 
of research translation and, ultimately, research impact. 
They also enable quantitative findings to be placed in 
context and are an opportunity to explain variances in 
research costs, outputs and impacts. Feedback received 
by the ARC as part of the development of its Engagement 
and Impact Assessment Framework indicates that a narra-
tive approach is the most appropriate method to convey 
information and data on Indigenous research particularly 
regarding engagement and impact.
Case studies have been the basis of the research evalua-
tion system currently used in the UK.5 Within the Payback 
Framework, case studies are developed retrospectively 
for selected research projects and used to validate 
impact data and to provide illustrations of high impact 
for different Payback categories.15 In FAIT, narratives 
are developed progressively along the research pathway 
and used for describing the often complex pathways for 
research translation.
In other applications of FAIT, these narratives have 
also been important vehicles for verifying the consistency 
of the impact findings generated from the economic 
assessment and Payback quantified metrics. In this appli-
cation, it is expected that the narratives are supported 
with evidence extracted from the quantified metrics and 
economic assessments, and will be informed by interviews 
at different points along the research pathway with key 
CRE-IQI researchers and key stakeholders including end 
users of the research such as health service staff, repre-
sentatives of peak bodies, government representatives 
and Indigenous community leaders. It is hoped that the 
collaborative and prospective approach to the develop-
ment of the narratives will render them less likely to be 
impacted by the biases that often characterise case studies 
based only on self-reports such as selective memory.32
limitations
This study is being conducted in a real-world setting, which 
presents some obvious limitations. Impact assessments are 
resource-intensive, and although the prospective collec-
tion of evidence is more cost-effective, not all the CRE-IQI 
Flagship projects will allow prospective collection of the 
required data. Final metrics for the Payback assessment 
and data for the narratives and economic assessments for 
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Figure 3 Hypothetical scorecard for a research project looking at increasing the delivery of cardiovascular risk assessments 
and follow-up for Aboriginal and Torres Strait Islander people.
each project will be based on what can feasibly be collected 
versus the ideal list of impact metrics and evidence. The 
lag between research translation and impact means that 
valuations may need to be undertaken with reference to 
interim rather than final impacts. For CRE-IQI Flagship 
projects that are further along the research pipeline, this 
constraint will be less problematic compared with proj-
ects that have commenced more recently. Conduct of the 
study in a real-world setting means there are no controls 
(counterfactuals); thus, attribution of impact for all five 
projects will be necessarily conservative. And finally, the 
FAIT framework is project-based and is being applied (as 
intended) to a select number of CRE-IQI projects that 
represent a major investment of the CRE. A limitation, 
therefore, is that this study will not assess the impact of 
CRE-IQI as a whole.
Phase IV
Reporting and recommendations around the implementation of 
FAIT
The results, including the narratives, will be summarised 
and reported by way of a scorecard (see figure 3 for 
hypothetical scorecard). This scorecard will form the 
basis of CRE-IQI reporting of the translation and impact 
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of its five Flagship projects, as well as feed into a more 
comprehensive evaluation of the CRE as an innovation 
platform (the details of which are not covered in this 
protocol).
The findings from the implementation of the FAIT 
Framework within CRE-IQI and specifically about its 
applicability within the Indigenous health research 
context will be compiled, and a workshop with key 
CRE-IQI researchers and stakeholders will be employed 
to discuss the findings and to obtain feedback with a 
view to the final refining of the framework for future 
use.
EThICS And dISSEMInATIon
The implementation of FAIT within CRE-IQI is funded as 
part of a nationally competitive grant (Grant ID 1078927) 
through the Australian NHMRC. The study, as described 
in this protocol, has received ethics approval from 
the University of Newcastle’s Human Research Ethics 
Committee (Ethics ID: H-2017–0026). While no partici-
pant details will be collected as part of the study, consent 
will be sought and recorded for each participant and asso-
ciated organisation.
It is anticipated that the results from the study 
described in this protocol will be presented in several 
related publications. The first will focus on the imple-
mentation of the framework (development of the 
programme logic) and its evaluation (did it work?). 
The second will summarise the learnings from the study 
and present recommendations for improving FAIT. The 
research impact assessment findings will be presented 
in a series of publications.
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